A detailed history of Mirabella Financial Services LLP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Mirabella Financial Services LLP holds 6,446 shares of VKTX stock, worth $405,904. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,446
Holding current value
$405,904
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$47.39 - $80.2 $305,475 - $516,969
6,446 New
6,446 $341,000
Q4 2022

Feb 13, 2023

BUY
$2.72 - $9.4 $54,884 - $189,673
20,178 New
20,178 $189,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.83B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.